External validation of the modified Glasgow prognostic score for renal cancer

Abstract

PURPOSE The modified Glasgow prognostic Score (mGPS) incorporates C-reactive protein and albumin as a clinically useful marker of tumor behavior. The ability of the mGPS to predict metastasis in localized renal cell carcinoma (RCC) remains unknown in an external validation cohort. PATIENTS AND METHODS Patients with clinically localized clear cell RCC were… (More)
DOI: 10.4103/0970-1591.124203

Topics

  • Presentations referencing similar topics